MSCM ventures into RM80BIL healthcare industry


(From left) GeneFlux Bioscience CEO Balaguru Naidu, MSCM Holdings executive chairman Datuk Teoh Hai Hin, MSCM Holdings executive director Jeff Chong, MMA president Dr Ganabaskaran Nadason and MMA honorary general secretary and Koperasi Persatuan Perubatan Malaysia chairman Dr Thirunavukarasu Rajoo at the agreement signing between MSCM Holdings subsidiary HS Bio Supplies and the cooperative on Aug 28,2020.

MSCM Holdings Berhad is venturing into medical supplies and support as it seeks to reduce reliance on its core business and tap into the RM80bil Malaysian healthcare industry.

The group through its subsidiary HS Bio Supplies Sdn Bhd (HSBS) intends to be involved in the business of trading and provision of bio supplies, healthcare products, medical equipment, supplements, test kits, vaccines, among others.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

ETA Group to dispose of stakes in two subsidiaries for RM22.73mil
Insas proposes disposal of up to 218 million Inari shares
Kawan Renergy posts RM2.04mil net profit in 3Q
MediAsas DRG pricing framework built on RM4.8bil in hospital billings
Astino’s FY26 net profit rises 44% on stronger export margins
Ringgit closes higher against US dollar despite fed rate hike expectations
Kinergy Advancement proposes private placement to raise up to RM79.75mil
MISC, Yinson Legacy and EPF continue talks on Yinson privatisation at RM2.35 a share
Favelle Favco secures RM88.8mil offshore crane orders
TSH Resources’ Indonesian unit fined RM42mil by forest enforcement task force

Others Also Read